Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism.

Radford-Smith, Daniel E; Patel, Preya J; Irvine, Katharine M; Russell, Anthony; Siskind, Dan; Anthony, Daniel C; Powell, Elizabeth E; Probert, Fay

Radford-Smith, Daniel E; Patel, Preya J; Irvine, Katharine M; Russell, Anthony; Siskind, Dan; Anthony, Daniel C; Powell, Elizabeth E; Probert, Fay.

Affiliation

Radford-Smith DE; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.
Patel PJ; Department of Chemistry, University of Oxford, Oxford, United Kingdom.
Irvine KM; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, United Kingdom.
Russell A; Institute for Liver and Digestive Health, University College London, London, United Kingdom.
Siskind D; The Liver Unit, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Anthony DC; Centre for Liver Disease Research, The University of Queensland, Brisbane, Australia.
Powell EE; Mater Research, The University of Queensland, Brisbane, Australia.
Probert F; Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia.

PLoS One ; 17(1): e0261555, 2022.

Article in En | MEDLINE | ID: mdl-34990473

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Serum / Depression / Lipid Metabolism / Metabolomics / Non-alcoholic Fatty Liver Disease / Lipoproteins Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google